Today before the opening bell, Dominovas Energy announced that it has entered a 3MW multi-year Power Provider Agreement (PPA) to provide electricity to the Somico Mine in the Democratic Republic of the Congo (DRC) via its proprietary RUBICON™ Solid Oxide Fuel Cell system. This news immediately follows a press release issued last week of a different multi-megawatt power provider agreement in the same country with the City of David. The two wins can be attributed to Dominovas Energy’s ongoing campaign to electrify the continent with its state-of-the-art, clean, reliable, and efficient source for power generation.

Located in the SANKURU/LUSAMBO region of the DRC, the Somico Mine has one of the largest certified concentrations of diamonds, gold and iron ore in Africa. The mine is one of several operated by SOMICO-RDC SARL. Dominovas Energy plans to use the Somico Mine project as a model for deploying RUBICON™ systems throughout Africa and other global markets. With the vast reserves of natural resources in Africa, the mining sector represents a tremendous opportunity for the company’s continued expansion across diverse applications of its proprietary fuel cell system. The mining sector in Africa represents a multibillion dollar industry with the potential to deploy more than 25,000 MW of power to mining operations and their communities.

Dominovas Energy anticipates beginning the physical deployment of the RUBICON™ in the Democratic Republic of Congo in Q4 of 2016. According to today’s press release, “The 3MW installation is a continuation of what is the largest single deployment of fuel cell technology on the continent of Africa, representing a paradigm shift in the DRC’s approach to addressing concerns regarding harmful carbon emissions, and to reducing the ever-expanding equipment maintenance and inefficiencies that are associated with increased costs, as are endemic with power generation from diesel generators, combined-cycle gas-fired turbine (CCGT) power plants, and other combustion-centric technologies.”

The company stated the RUBICON™ will produce over 25.5 million kWh of clean, efficient, and reliable electricity every year with the 3MW Power Provider Agreement (PPA) yielding more than US$107 million in guaranteed revenue over the multi-year term PPA.

Emilio De Jesus, President of Dominovas Energy’s Africa Division, commented, “I am thrilled that my executive management team has given me the latitude to execute to this scale and magnitude. Somico Mine will establish the new blueprint for how mine operators in Africa and other emerging markets support their mining operations, using off-grid ‘clean’ energy solutions.”

Dominovas Energy’s COO, Michael Watkins, added, “This is an exciting day for Dominovas Energy. Today, we are reaping the benefits of sales cycle maturation that has required patience, diligence, and careful planning. As a result, our pipeline of projects is creating the type of production scale that will promote efficient and cost-effective manufacturing. Our signed PPAs will further support job creation and expansion domestically, as the RUBICON™ is manufactured and supported by a robust supply-chain in the U.S.”

For more information on Dominovas Energy and its fuel cell technology, visit www.dominovasenergy.com

Let us hear your thoughts: Dominovas Energy Corp. Message Boards

View Systems has already made an impact in the security industry with its technologically advanced walk-through concealed weapons detection system, ViewScan. In a recent news release, however, the company announced that it had put the wheels into motion to build on the success of its proprietary platform by filing for patent protection and beginning early manufacturing efforts for an enhanced ViewScan product.

When released, the new ViewScan will address many of the issues that limit ordinary metal detectors, particularly in terms of the amount of time it takes to detect a threat, while maintaining all of the best features of the company’s current product. Using groundbreaking technology, the company’s new and improved system will provide clients with enhanced threat recognition and facial identification.

“The person is safely analyzed and potential threat objects are located and shown on live video,” John Sarman, chief engineer of View Systems, stated in a news release. “The instant video feed can be coupled with facial identification methods. The complete system becomes a verification of an identified or sought for individual and whether that individual possesses a threat.”

In recent years, the security industry has established a presence among the fastest-growing sectors of the global economy. According to a report by Security Magazine, the U.S. security industry is currently a $350 billion market, with approximately 80 percent of total spending being completed in the private sector. Through its established presence within the thriving industry, View Systems has a formidable platform to realize enhanced returns in the future.

In May, View Systems continued to expand its presence in the industry through a partnership with Xecutive Security Investigations Group, which gave the company improved access to a broad range of potential clients, including Maryland state and local governments. Earlier this month, the company reaffirmed its commitment to growth through the announcement of continued deployment at banks, police stations and additional schools throughout Michigan, Texas and California.

“We’re excited about the momentum we have moving forward as more customers recognize the benefits of our system in providing efficient security measures for their facilities,” stated Gunther Than, chief executive officer of View Systems.

For more information, visit www.viewsystems.com

Let us hear your thoughts: View Systems, Inc. Message Board

Houston-based Well Power is targeting the oil and gas industry with a particular focus on commercializing a patented solution to convert flared, shut-in and stranded gas into clean power and engineered fuels. Using this mobile, high-yield technology licensed from ME Resources Corp. (“MEC”), Well Power aims to reduce waste emission and capitalize on this niche market of the oil and gas industry.

Each year, billions of cubic meters of natural gas are flared at oil production sites all over the world. According to the World Bank Group, gas flaring not only wastes a valuable energy resource, it also contributes to climate change by releasing more than 300 million tons of CO2 into the atmosphere.

In April, The World Bank announced that chief executives from major oil companies, including Royal Dutch Shell (NYSE:RDS-A, NYSE:RDS-B) and Statoil CEO (NYSE:STO), were convening with senior government officials from several oil-producing countries to commit to ending routine gas flaring. Already endorsed by nine countries, 10 oil companies and a handful of development institutions, United Nations Secretary-General Ban Ki-moon and World Bank Group President Jim Yong Kim concurrently launched the “Zero Routine Flaring by 2030” initiative to end routine gas flaring at oil production sites by the year 2030.

“Gas flaring is a visual reminder that we are wastefully sending CO2 into the atmosphere,” Jim Yong Kim stated in an earlier news release. “We can do something about this. Together we can take concrete action to end flaring and to use this valuable natural resource to light the darkness for those without electricity.”

Well Power is gearing up to participate in this broader movement through the commercialization of the licensed Micro-Refinery Unit (MRU), which processes raw natural gas into green fuel (such as diluents, drop-in diesel and pipeline quality synthetic crude) and clean power. MEC’s solution simultaneously reduces CO2 emissions while creating revenue streams with minimal capital expenditure.

Well Power has secured the licensing rights to Texas with the first right of refusal on the other U.S. states, such as North Dakota, where gas flaring is a significant and concern. The company plans to be able to provide its technology with full-service engineering, design, construction, modular fabrication, maintenance and construction management services to clients in the upstream areas of exploration and production.

In addition, Well Power will offer consulting services, process assessments, facility appraisals, feasibility studies, technology evaluations, project finance structuring and support, and multi-client subscription services.

Leveraging the potential of the MRUs, Well Power is aligned with the Zero Routine Flaring by 2030 initiative and offers the opportunity to create value from a wasted resource while enabling wider access to energy, improved environmental conditions, and economic development for local populations.

For more information, visit www.wellpowerinc.com

Let us hear your thoughts: Well Power Inc. Message Board

GrowBLOX Sciences has entered into a Note Purchase Agreement with Pacific Leaf Ventures, LP in which Pacific Leaf has agreed to make an installment loan to GrowBLOX of up to $1.75 million. According to an SEC filing, the financing provides the funding for GrowBLOX subsidiary GB Sciences Nevada, LLC to acquire and install an operating facility, equipment, and other tangible assets for the cultivation of cannabis and the extraction of oils and other constituents present in cannabis, in adherence to Nevada legal requirements.

GBS Nevada holds a provisional certificate from the Division of Public & Behavioral Health of the Nevada Department of Health and Human Services to operate an establishment to cultivate medical cannabis in Clark County Nevada. The certificate is considered provisional until the establishment is in compliance with applicable local government requirements and has received a state business operating license.

In a related development, GrowBLOX also entered into an exclusive perpetual license agreement to make use of Pacific Leaf’s intellectual property (IP) for the cultivation of cannabis and extraction of oils and other strains of cannabis that it has developed or acquired for the sole use of GBS Nevada in its operations within the state of Nevada. In consideration for the license, GrowBLOX has agreed to pay Pacific Leaf a 14 percent royalty for a period of five years, and a 7 percent royalty each year for five years thereafter.

As part of the Pacific Leaf license, GrowBLOX was also granted the exclusive perpetual right in Nevada to use certain proprietary techniques developed by Pacific Leaf for the extraction of oils from the product grown in the Nevada facility, using the extraction equipment financed by the proceeds of the Pacific Leaf loan. In connection therewith, GrowBLOX agreed to pay a royalty of $2 per extracted gram for a period of five years.

GrowBLOX said it believes that the rights to Pacific Leaf’s IP will give GBS Nevada a “significant competitive advantage in the Nevada cannabis market.” This advantage is complementary to GrowBLOX’s broader business strategy to integrate state-of-the-art technologies in plant biology, cultivation, and post-production processes to optimize safe, consistent medical cannabis.

For more information, visit www.gbsciences.com

Let us hear your thoughts: GrowBLOX Sciences, Inc. Message Board

Earlier this morning Net Element announced that CEO Oleg Firer will be participating in a discussion to be held June 19th 2015 at the St. Petersburg International Economic Forum.

Fellow panelists will include senior executives from Citi, Accenture, Telenor Group, Visa Inc., IBM and Sberbank. The discussion is entitled “THE FUTURE OF THE ELECTRONIC WALLET AND THE MODERNIZATION OF GLOBAL PAYMENT PLATFORMS.”

The event’s website states, “SPIEF gathers the leading decision-makers of the emerging economic powers to identify and deliberate the key challenges facing Russia, emerging markets, and the world at large, while engaging communities to find common purpose and establish frameworks to forge solutions which will drive the growth and stability agenda.”

For more information about the discussion and SPIEF, visit http://www.forumspb.com/en/2015/sections/50/materials/260/sessions/1121

Rosetta Genomics, Ltd. (NASDAQ: ROSG) leverages an integrative research platform to develop and commercialize a full range of microRNA-based molecular diagnostics and address critical needs in cancer and other disease areas. Building on its proprietary platform technologies and a strong IP portfolio, the company is working to solve unmet medical needs and improve the lives of patients through a proven combination of diagnostic expertise and therapeutic innovations.

The company’s current product pipeline includes an assortment of unique diagnostic tests for a collection of medical conditions – including thyroid neoplasia, heart failure, kidney rejection and Alzheimer’s disease. In recent months, Rosetta has worked to build on this pipeline and expand its presence in the industry, most notably through the acquisition of PersonalizeDx in April. PersonalizeDx is a rapidly growing molecular diagnostics and services company serving community-based pathologists, urologists, oncologists and other reference laboratories across the United States.

“The acquisition of PersonalizeDx will have wide-ranging, positive financial, commercial, operational and pipeline impact on Rosetta Genomics, and brings with it exceptional talent to complement the industry-leading team at Rosetta Genomics,” stated Kenneth A. Berlin, president and chief executive officer of Rosetta, in a recent news release. “In joining forces with PersonalizeDx, Rosetta Genomics will gain critically important commercial and revenue scale in the marketplace for oncology diagnostics.”

In May, Rosetta built on the momentum gained from its acquisition by releasing OncoGxOne™, the company’s next-generation sequencing panel that detects a vast number of genetic alterations implicated in cancer to provide clear, concise and actionable clinical recommendations from a single, comprehensive test. Moving forward, OncoGxOne™ will compete with currently available genomic profiling offerings through next-generation sequencing platforms that can identify potentially actionable cancer-driving mutations, which can be targeted by specific therapies.

“We look forward to a successful commercial launch for OncoGxOne™ with our recently-expanded sales force and expect that over time it will become an important contributor to our revenues,” concluded Berlin.

Rosetta’s recent efforts have strategically positioned the company to realize significant increases in revenue in the coming years. Based on PersonalizeDx’s 2014 revenue, which was $6.9 million, the company has modified its financial model, leading to forecast revenue of $18.5 million in 2016. For prospective investors, this potential growth could provide the opportunity for significant returns in the future.

For more information, visit www.rosettagenomics.com

Soul and Vibe Interactive, Inc. (OTCQB: SOUL) is an innovative video and computer games company focused on developing and publishing standout games. The company specializes in the creation of original intellectual property (IP) and has extensive experience licensing world-renowned brands from influential companies, including General Mills (GIS) and Deere & Company (DE). SOUL’s proven business model centers on multi-platform support, allowing the company to market licensed-brand and original IP-based games that can be played on consoles, mobile devices, and personal computers.

According to a report by PricewaterhouseCoopers, consumer spending on console, mobile and personal computer gaming software topped $56 billion in 2010, and gaming industry revenue is projected to reach $82 billion this year. Despite the overall maturity of the gaming industry’s distribution and marketing efforts in retail settings, digital distribution is forcing the market to evolve, putting SOUL in a strong position to capitalize moving forward. Through partnerships with some of the world’s most technically sophisticated software developers, the company is in a strong position to increase market share through the creation and licensing of engaging, highly accessible and affordable games and entertainment experiences.

In April, SOUL announced the latest addition to its IP portfolio, SirVival, a fast-paced adventure game. In keeping with the company’s multi-platform strategy, the game will be released on Apple’s App Store, Google Play, Amazon, Microsoft Store Marketplace and Facebook. Earlier this month, the company continued efforts to grow brand recognition and created an additional channel to realize sustainable returns through the announcement of Soul and Vibe Music, a publishing label through which music singles and soundtracks will be released. Soul and Vibe Music is expected to be released via digital download on iTunes, Spotify, Google Play, Amazon, Rdio, Deezer, Tidal, YouTube Music Key, Beats/MediaNet and more.

“Soul and Vibe is a name that lends itself to a wide variety of entertainment mediums,” Peter Anthony Chiodo, president and chief executive officer of SOUL, stated in a news release. “While we work as a team to expand our portfolio of published content, it makes sense for us to separately leverage select elements of that content in unique ways so it can potentially expand monetization opportunities for the company.”

Moving forward, SOUL will look to continue expanding its presence in the gaming industry through strategic licensing agreements and the creation and utilization of IP. For prospective investors, the company’s continued progress toward the launch of SirVival makes it an intriguing option to consider in the months to come.

For more information, visit www.soulandvibe.com

Ohr Pharmaceutical is an ophthalmology research and development company. Its lead product, Squalamine, is currently being studied as an eye drop formulation in several company sponsored and investigator sponsored phase II clinical trials for various back-of-the-eye diseases, including wet age-related macular degeneration (wet AMD), retinal vein occlusion, diabetic macular edema and proliferative diabetic retinopathy. The company’s second product, OHR/AVR118, is designed to treat cancer cachexia, which is commonly known as wasting syndrome. Through these two candidates, Ohr’s product pipeline offers a new ray of hope to patients suffering from these devastating diseases.

Unlike current wet AMD treatment options, which are administered via injection directly into the eye, Ohr’s innovative Squalamine formulation is designed for self-administration, eliminating the need for painful intravitreal injections and providing a significant cost advantage, as compared to the current standards of care. According to a report by the National Eye Institute, wet AMD is a common eye condition and a leading cause of vision loss among people aged 50 and older, affecting over 1.75 million patients in the United States alone. Through the development of Squalamine, Ohr could effectively revolutionize the standard treatment option for this condition, creating a formidable platform to realize significant growth in the ophthalmology market.

In addition to Squalamine, Ohr is addressing a vastly underserved market through the continued development of OHR/AVR118 for the treatment of cancer cachexia. Cancer cachexia is a severe wasting disorder characterized by a significant loss of appetite, weight loss, fatigue, weakness and muscle atrophy. Currently, there is no FDA approved drug for the treatment of this debilitating condition, providing Ohr with another opportunity to realize sustainable increases in shareholder returns.

With a product pipeline including two unique drug candidates in four distinctive indications currently undergoing phase II clinical trials, Ohr is continuing to set the stage for rapid increases in market share in the years to come. For prospective investors, this progress makes Ohr an intriguing option moving forward.

For more information, visit www.ohrpharmaceutical.com

Vycor Medical, Inc. (OTCQB: VYCO) is changing and improving lives every day by providing the medical community with innovative and superior surgical and therapeutic tools, including a growing portfolio of FDA-cleared medical solutions. The company currently operates two unique but complementary business units, Vycor Medical and NovaVision, which adopt a minimally or non-invasive approach to a collection of underserved medical applications.

Through its Vycor Medical unit, the company designs, develops and markets the ViewSite Brain Access System (VBAS), a proprietary suite of clear cylindrical disposable devices used to gain access to specific neurological sites, such as tumors within the brain. Vycor’s innovative medical instruments are designed to optimize neurosurgical site access, reduce patient risk, accelerate recovery and add tangible value to the professional medical community.

In recent months, the company has made significant headway toward expanding VBAS’s presence within the medical industry, increasing the number of U.S. hospitals for which the system is approved to more than 190 during the first quarter of 2015. In large part, this growth has come as a result of increasingly prevalent scientific data on the system. According to a recently released study on VBAS published by surgeons from Sapporo Medical University in Japan, the suite is believed to provide a safer, more reliable, and less invasive method for the treatment of deep-seated brain tumors.

“We continue to make good progress with our VBAS product and the new studies we are anticipating this year together with the launch of additional products makes me confident this will translate into increased VBAS penetration and greater market acceptance during the course of this year,” stated Peter Zachariou, chief executive officer of Vycor, in a recent news release.

Through its NovaVision unit, Vycor targets a substantial and largely unaddressed market of people who have lost their sight as a result of stroke or traumatic brain injury. The company’s family of therapies, which are clinically supported by decades of scientific research, both restore and help to compensate for lost vision.

NovaVision’s unique product offerings have gained significant industry traction in recent months. Late in 2014, the company received receipt of approval from HealthSouth to offer the NovaVision VIDIT diagnostic device, and, earlier this month, Vycor continued on this success by partnering with HealthSouth for a second time to make available its NeuroEyeCoach Professional Center therapy program. These two agreements provide the company with access to a potentially massive source of patients, as HealthSouth is one of the largest providers of post-acute healthcare services in the country.

“NovaVision is now positioned, for the first time, with the suite of therapies and product offerings to deliver on our strategic vision: to provide a clinically supported, affordable and scalable visual therapy solution offering broad benefits to those suffering from visual impairment following neurological damage,” continued Zachariou.

Moving forward, Vycor is in an increasingly strong position to realize enhanced returns. Despite a slim decrease in reported year-over-year revenue for the first quarter of 2015, the company’s recently announced agreements with HealthSouth, as well as expanding product approval rates for the VBAS, make Vycor an intriguing option for prospective investors in the months to come.

For more information, visit www.vycormedical.com

Pure Hospitality Solutions, in an effort to continue building shareholder confidence, recently released a collection of site design snapshots for its upcoming Central American-Caribbean online travel hub, Oveedia.

“[W]e are currently at a stage where testing will soon begin and an early launch is likely,” Melvin Pereira, president and chief executive officer of Pure, stated in a news release. “Our programmers are working tirelessly to ensure Oveedia’s launch is not only accelerated, but that an ultra-friendly user experience is achieved by front-end consumers.”

With the snapshots, Pure is providing shareholders with a glimpse into the style, functionality and design of the Oveedia platform. Along with two unique desktop versions of its design, the preview also includes both tablet and mobile design snapshots, highlighting the quantifiable progress of Pure in recent months.

“We are exploring two differently designed, ultra-responsive versions, all shown as the platform will appear on a desktop, smartphone or tablet,” continued Pereira. “We are on our way to having one of the most incredible assets in the history of our organization.”

In May, Pure took a significant step toward increasing the potential value of Oveedia by becoming a member of the Sabre Travel Network. Through this agreement, the company gained access to a $7 billion booking network, including more than 125,000 hotels, 400 airlines, 16 cruise lines and 25 car rental selections. In addition to its partnership with Sabre, Pure has also made major strides toward a sustainable presence in the growing Central American-Caribbean travel industry through the continued expansion of its standalone travel network. Last week, the company added Jaco Tour Company to the fold, and expansion to approximately 300 hotels and travel-related businesses is expected by the end of the year.

According to a report by Amadeus, the online travel agency segment in the Latin American market is expected to account for $98.5 billion in 2016, providing Pure with the opportunity to realize rapid increases in market share following Oveedia’s initial release. Integration with the Sabre Travel Network, as well as continued expansion of Pure’s standalone region-specific travel network, should make Oveedia a strong acquisition target for larger, globally dominant OTAs – including Expedia and Priceline – in the years to come. For prospective shareholders, the impending launch of Oveedia makes Pure an intriguing investment opportunity moving forward.

For more information on Pure Hospitality Solutions, visit www.purenow.solutions

Let us hear your thoughts: Oriens Travel and Hotel Management Corp. Message Board